ZIMMER BIOMET HOLDINGS, INC. Deferred Income Tax Expense (Benefit)
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Deferred Income Tax Expense (Benefit) of -$87.20 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-02-20
- ZIMMER BIOMET HOLDINGS, INC. deferred income tax expense (benefit) for the quarter ending 2016-12-31 was -$180.80M.
- ZIMMER BIOMET HOLDINGS, INC. deferred income tax expense (benefit) for the quarter ending 2016-09-30 was -$25.10M.
- ZIMMER BIOMET HOLDINGS, INC. deferred income tax expense (benefit) for fiscal 2025 was -$87.20M.
- ZIMMER BIOMET HOLDINGS, INC. deferred income tax expense (benefit) for fiscal 2024 was -$47.70M.
- ZIMMER BIOMET HOLDINGS, INC. deferred income tax expense (benefit) for fiscal 2023 was -$96.30M.
- ZIMMER BIOMET HOLDINGS, INC. deferred income tax expense (benefit) for fiscal 2022 was -$64.40M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | -$87.20M 10-K · filed 2026-02-20 | ||||
| 2024-12-31 | -$47.70M 10-K · filed 2026-02-20 | ||||
| 2023-12-31 | -$96.30M 10-K · filed 2026-02-20 | ||||
| 2022-12-31 | -$64.40M 10-K · filed 2025-02-25 | ||||
| 2021-12-31 | -$102.10M 8-K · filed 2024-08-07 | -$149.70M 10-K · filed 2022-02-25 | |||
| 2020-12-31 | $39.40M 10-K · filed 2023-02-24 | $12.00M 10-K · filed 2021-02-22 | |||
| 2019-12-31 | -$587.80M 8-K · filed 2022-06-22 | -$538.70M 10-K · filed 2020-02-21 | |||
| 2018-12-31 | $13.40M 10-K · filed 2021-02-22 | ||||
| 2017-12-31 | -$1.78B 10-K · filed 2020-02-21 | ||||
| 2016-12-31 | -$180.80M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$205.90M derived: sum of 2 quarters · filed 2019-02-26 | -$153.20M 10-K · filed 2019-02-26 | ||
| 2016-09-30 | -$25.10M 10-Q · filed 2016-11-08 | $27.60M 10-Q · filed 2016-11-08 | |||
| 2015-12-31 | -$164.00M 10-K · filed 2018-02-27 | ||||
| 2014-12-31 | -$90.50M 10-K · filed 2017-03-01 | -$84.20M 10-K · filed 2015-02-23 | |||
| 2013-12-31 | -$126.20M 10-K · filed 2016-02-29 | ||||
| 2012-12-31 | -$64.80M 10-K · filed 2015-02-23 | ||||
| 2011-12-31 | -$19.70M 10-K · filed 2014-02-28 | ||||
| 2010-12-31 | -$72.50M 10-K · filed 2013-02-27 | ||||
| 2009-12-31 | -$19.70M 10-K · filed 2012-02-27 | ||||
| 2008-12-31 | $2.00M 10-K · filed 2011-02-25 | ||||
| 2007-12-31 | $63.90M 10-K · filed 2010-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |